Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Evette Mitkov

Novo Nordisk Rises Despite Metsera Loss, Slashes Wegovy Price In India

Novo Nordisk

Novo Nordisk A/S (NYSE:NVO) shares are trading higher on Tuesday. The company recently lost its bidding war for Metsera Inc (NASDAQ:MTSR).

What Happened: According to Reuters, Pfizer Inc (NYSE:PFE) won the bidding war against Novo Nordisk and will purchase Metsera for $10 billion. The board of Metsera accepted Pfizer’s offer, stating that Novo’s bid carried too much legal and regulatory risks following antitrust concerns raised by the Federal Trade Commission.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.